ArticleScientific reports2022

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine.

Chiara Agrati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.